{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:57:05Z","timestamp":1784937425725,"version":"3.55.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Osteolytic bone disease is a condition of imbalanced bone homeostasis, characterized mainly by excessive bone-resorptive activity, which could predispose these populations, such as the old and postmenopausal women, to developing high risk of skeletal fragility and fracture. The nature of bone homeostasis is the coordination between the osteoblasts (OBs) and osteoclasts (OCs). Abnormal activation of osteoclasts (OCs) could compromise the bone homeostasis, constantly followed by a clutch of osteolytic diseases, including postmenopausal osteoporosis, osteoarthritis, and rheumatoid arthritis. Thus, it is imperatively urgent to explore effective medical interventions for patients. The traditional Chinese medicine (TCM) gamabufotalin (CS-6) is a newly identified natural product from Chansu and has been utilized for oncologic therapies owing to its good clinical efficacy with less adverse events. Previous study suggested that CS-6 could be a novel anti-osteoporotic agent. Nevertheless, whether CS-6 suppresses RANK-(receptor activator of nuclear factor-\u03ba B ligand)\/TRAF6 (TNF receptor-associated factor 6)-mediated downstream signaling activation in OCs, as well as the effects of CS-6 on OC differentiation <jats:italic>in vivo<\/jats:italic>, remains elusive. Therefore, in this present study, we aimed to explore the biological effects of CS-6 on osteoclastogenesis and RANKL-induced activation of related signaling pathways, and further to examine the potential therapeutic application in estrogen-deficient bone loss in the mice model. The results of <jats:italic>in vitro<\/jats:italic> experiment showed that CS-6 can inhibit RANKL-induced OC formation and the ability of bone resorption in a dose-dependent manner at both the early and late stages of osteoclastogenesis. The gene expression of OC-related key genes such as tartrate-resistant acid phosphatase (TRAP), CTSK, DC-STAMP, MMP9, and \u03b23 integrin was evidently reduced. In addition, CS-6 could mitigate the systemic estrogen-dependent bone loss and pro-inframammary cytokines in mice <jats:italic>in vivo<\/jats:italic>. The molecular mechanism analysis suggested that CS-6 can suppress RANKL\/TRAF6-induced early activation of NF-\u03baB and ERK\/MAPK signaling pathways, which consequently suppressed the transcription activity of c-Fos and NFATc1. Taken together, this present study provided ample evidence that CS-6 has the promise to become a therapeutic candidate in treating osteolytic conditions mediated by elevated OC formation and bone resorption.<\/jats:p>","DOI":"10.3389\/fphar.2021.629968","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T17:04:20Z","timestamp":1619197460000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Gamabufotalin Inhibits Osteoclastgenesis and Counteracts Estrogen-Deficient Bone Loss in Mice by Suppressing RANKL-Induced NF-\u03baB and ERK\/MAPK Pathways"],"prefix":"10.3389","volume":"12","author":[{"given":"Kaiqiang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanqi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Huan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changzhen","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingchuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.joca.2015.10.008","article-title":"Osteoclasts are recruited to the subchondral bone in naturally occurring post-traumatic equine carpal osteoarthritis and may contribute to cartilage degradation","volume":"24","author":"Bertuglia","year":"2016","journal-title":"Osteoarthr. Cartil."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/jbmr.5650100706","article-title":"Characterization of MCSF-induced proliferation and subsequent osteoclast formation in murine marrow culture","volume":"10","author":"Biskobing","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"111470","DOI":"10.1016\/j.yexcr.2019.06.015","article-title":"Nirogacestat suppresses RANKL-induced osteoclast formation in vitro and attenuates LPS-induced bone resorption in vivo","volume":"382","author":"Chen","year":"2019","journal-title":"Exp. Cell Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1002\/jcp.25389","article-title":"DC-STAMP: a key regulator in osteoclast differentiation","volume":"231","author":"Chiu","year":"2016","journal-title":"J. Cell Physiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"115707","DOI":"10.1016\/j.bone.2020.115707","article-title":"PMSA prevents osteoclastogenesis and estrogen-dependent bone loss in mice","volume":"142","author":"Cho","year":"2021","journal-title":"Bone"},{"key":"B8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bone.2017.01.002","article-title":"CCL3 and MMP-9 are induced by TL1A during death receptor 3 (TNFRSF25)-dependent osteoclast function and systemic bone loss","volume":"97","author":"Collins","year":"2017","journal-title":"Bone"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1128\/mcb.16.4.1295","article-title":"Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation","volume":"16","author":"DiDonato","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"41411","DOI":"10.1038\/srep41411","article-title":"Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-\u03baB, ERK and JNK signaling pathways","volume":"7","author":"Feng","year":"2017","journal-title":"Sci. Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1101\/gad.187900","article-title":"Fra-1 replaces c-Fos-dependent functions in mice","volume":"14","author":"Fleischmann","year":"2000","journal-title":"Genes Dev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/cncr.11128","article-title":"Antitumor effects of bisphosphonates","volume":"97","author":"Green","year":"2003","journal-title":"Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41413-018-0019-6","article-title":"Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts","volume":"6","author":"Han","year":"2018","journal-title":"Bone Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.3389\/fphar.2019.01344","article-title":"Therapeutic anabolic and anticatabolic benefits of natural Chinese medicines for the treatment of osteoporosis","volume":"10","author":"He","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11657-016-0301-4","article-title":"New insights into the tonifying kidney-yin herbs and formulas for the treatment of osteoporosis","volume":"12","author":"He","year":"2017","journal-title":"Arch. Osteoporos."},{"key":"B16","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.oraloncology.2013.06.008","article-title":"Osteonecrosis of the jaw-prevention and treatment strategies for oral health professionals","volume":"49","author":"Hinchy","year":"2013","journal-title":"Oral Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00210-017-1419-7","article-title":"Bufalin attenuates cancer-induced pain and bone destruction in a model of bone cancer","volume":"390","author":"Ji","year":"2017","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI91086","article-title":"Osteoclast-secreted SLIT3 coordinates bone resorption and formation","volume":"128","author":"Kim","year":"2018","journal-title":"J. Clin. Invest."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/s41467-017-01527-y","article-title":"DJ-1 controls bone homeostasis through the regulation of osteoclast differentiation","volume":"8","author":"Kim","year":"2017","journal-title":"Nat. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/s0092-8674(00)80290-1","article-title":"Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op\/op mice","volume":"89","author":"Lagasse","year":"1997","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","first-page":"115056","DOI":"10.1016\/j.bone.2019.115056","article-title":"IDH2 deficiency increases bone mass with reduced osteoclastogenesis by limiting RANKL expression in osteoblasts","volume":"129","author":"Lee","year":"2019","journal-title":"Bone"},{"key":"B23","doi-asserted-by":"publisher","first-page":"30736","DOI":"10.1074\/jbc.273.46.30736","article-title":"Recombinant IkappaB kinases alpha and beta are direct kinases of Ikappa Balpha","volume":"273","author":"Li","year":"1998","journal-title":"J. Biol. Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41419-019-1353-3","article-title":"TRAIL inhibits RANK signaling and suppresses osteoclast activation via inhibiting lipid raft assembly and TRAF6 recruitment","volume":"10","author":"Liao","year":"2019","journal-title":"Cell Death Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1172\/JCI64840","article-title":"Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation","volume":"123","author":"Lotinun","year":"2013","journal-title":"J. Clin. Invest."},{"key":"B26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.15386\/cjmed-838","article-title":"Observational study of the bisphosphonate-related osteonecrosis of jaws","volume":"91","author":"Lungu","year":"2018","journal-title":"Clujul Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1002\/cncr.24602","article-title":"Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer","volume":"115","author":"Meng","year":"2009","journal-title":"Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1476-4598-12-33","article-title":"Hellebrin and its aglycone form hellebrigenin display similar in vitro growth inhibitory effects in cancer cells and binding profiles to the alpha subunits of the Na+\/K+-ATPase","volume":"12","author":"Banuls","year":"2013","journal-title":"Mol. Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bcp.2016.04.010","article-title":"Pharmacological inhibition of cathepsin K: a promising novel approach for postmenopausal osteoporosis therapy","volume":"117","author":"Mukherjee","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/bonekey.2012.183","article-title":"Bone cell communication factors and Semaphorins","volume":"1","author":"Negishi-Koga","year":"2012","journal-title":"Bonekey Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jep.2013.03.066","article-title":"Medicinal plants of genus Curculigo: traditional uses and a phytochemical and ethnopharmacological review","volume":"147","author":"Nie","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.18632\/aging.102796","article-title":"Metformin coordinates osteoblast\/osteoclast differentiation associated with ischemic osteonecrosis","volume":"12","author":"Park","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.3390\/molecules24101871","article-title":"Icariin prevents diabetes-induced bone loss in rats by reducing blood glucose and suppressing bone turnover","volume":"24","author":"Qi","year":"2019","journal-title":"Molecules"},{"key":"B34","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j10.1016\/j.bbrc.2013.12.029","article-title":"Dioscin inhibits osteoclast differentiation and bone resorption though down-regulating the Akt signaling cascades","volume":"443","author":"Qu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.bone.2019.06.023","article-title":"The osteoclast, a target cell for microorganisms","volume":"127","author":"Raynaud-Messina","year":"2019","journal-title":"Bone"},{"key":"B36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bone.2017.06.020","article-title":"Postmenopausal osteoporosis in rheumatoid arthritis: the estrogen deficiency-immune mechanisms link","volume":"103","author":"Sapir-Koren","year":"2017","journal-title":"Bone"},{"key":"B37","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s00223-008-9127-4","article-title":"Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients","volume":"82","author":"Shidara","year":"2008","journal-title":"Calcif Tissue Int."},{"key":"B38","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.0105-2896.2009.00849.x","article-title":"Transcriptional regulation of bone and joint remodeling by NFAT","volume":"233","author":"Sitara","year":"2010","journal-title":"Immunol. Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3389\/fphar.2020.00360","article-title":"Pregnenolone inhibits osteoclast differentiation and protects against lipopolysaccharide-induced inflammatory bone destruction and ovariectomy-induced bone loss","volume":"11","author":"Sun","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/s1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"","journal-title":"Dev. Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/416744a","article-title":"RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta","volume":"416","author":"Takayanagi","year":"","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.18632\/oncotarget.6514","article-title":"Gamabufotalin, a major derivative of bufadienolide, inhibits VEGF-induced angiogenesis by suppressing VEGFR-2 signaling pathway","volume":"7","author":"Tang","year":"2016","journal-title":"Oncotarget"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1073\/pnas.0708576105","article-title":"RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation","volume":"105","author":"Vaira","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B44","doi-asserted-by":"publisher","first-page":"ii83","DOI":"10.1136\/ard.62.suppl_2.ii83","article-title":"Signalling in osteoclasts and the role of Fos\/AP1 proteins","volume":"62","author":"Wagner","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41467-019-14146-6","article-title":"Mechanical sensing protein PIEZO1 regulates bone homeostasis via osteoblast-osteoclast crosstalk","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"B46","doi-asserted-by":"publisher","first-page":"111977","DOI":"10.1016\/j.jep.2019.111977","article-title":"Integrated pathological cell fishing and network pharmacology approach to investigate main active components of Er-Xian decotion for treating osteoporosis","volume":"241","author":"Wang","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s13287-019-1500-x","article-title":"Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-\u03baB and NFATc1 activation","volume":"10","author":"Wu","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jep.2015.02.016","article-title":"Effect of bajijiasu isolated from Morinda officinalis F. C. how on sexual function in male mice and its antioxidant protection of human sperm","volume":"164","author":"Wu","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1038\/s41467-018-05244-y","article-title":"Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss","volume":"9","author":"Xiong","year":"2018","journal-title":"Nat. Commun."},{"key":"B50","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/1476-4598-13-203","article-title":"Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKK\u03b2\/NF-\u03baB signaling pathway in lung cancer cells","volume":"13","author":"Yu","year":"2014","journal-title":"Mol. Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"15725","DOI":"10.18632\/oncotarget.7398","article-title":"Gamabufotalin triggers c-Myc degradation via induction of WWP2 in multiple myeloma cells","volume":"7","author":"Yu","year":"2016","journal-title":"Oncotarget"},{"key":"B52","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.intimp.2018.05.030","article-title":"A flavonoids compound inhibits osteoclast differentiation by attenuating RANKL induced NFATc-1\/c-Fos induction","volume":"61","author":"Zhang","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"76551","DOI":"10.18632\/oncotarget.10388","article-title":"Quantitative proteomics reveals molecular mechanism of gamabufotalin and its potential inhibition on Hsp90 in lung cancer","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1002\/jbmr.3172","article-title":"mTORC1 inhibits NF-\u03baB\/NFATc1 signaling and prevents osteoclast precursor differentiation, in vitro and in mice","volume":"32","author":"Zhang","year":"2017","journal-title":"J. Bone Miner Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000450754","article-title":"Bufalin inhibits the inflammatory effects in asthmatic mice through the suppression of nuclear factor-kappa B activity","volume":"99","author":"Zhang","year":"2017","journal-title":"Pharmacology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/jbmr.3655","article-title":"The novel p38 inhibitor, Pamapimod, inhibits osteoclastogenesis and counteracts estrogen-dependent bone loss in mice","volume":"34","author":"Zhao","year":"2019","journal-title":"J. Bone Miner Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/jbmr.2771","article-title":"Dihydroartemisinin, an anti-malaria drug, suppresses estrogen deficiency-induced osteoporosis, osteoclast formation, and RANKL-induced signaling pathways","volume":"31","author":"Zhou","year":"2016","journal-title":"J. Bone Miner Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.629968\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T17:04:25Z","timestamp":1619197465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.629968\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":57,"alternative-id":["10.3389\/fphar.2021.629968"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.629968","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,23]]},"article-number":"629968"}}